/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
BACKGROUND OF BUSINESS COMBINATION On June 9, 2021 (the Closing Date ), Nautilus Biotechnology, Inc., a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp III ( ARYA )), consummated the business combination (the Business Combination ) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the Business Combination Agreement ), by and among ARY…
$0.97
$0.01 (-0.62%)
EOD Sep 18, 2026
Negative free cash flow of -$52M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$57M
▲ +16.6% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
-$51M
▲ +15.2% YoY
Op. Cash Flow (TTM)
-$50M
▲ +14.3% YoY
Net Debt
-$67M
Net Cash Position
Cash & Equiv.
$96M
Continue Research
SourceComputed from the 10-Q filed 28 Apr 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 29 Jul 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.